|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.85 CNY | -1.46% |
|
+0.86% | +6.98% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 4.71% | 5.19% | 14.68x | 2.75x | 0.61x | 4.86x | 8.02x | 3.22B | |
| -.--% | -.--% | 18.44x | 1.63x | 0.79x | 12.41x | 13.33x | 15.97B | |
| 0.94% | 1.18% | 23.66x | 2.66x | 0.94x | 15.91x | 16.22x | 7.28B | |
| 2.16% | 2.48% | 17.27x | 1.81x | 0.78x | 8.13x | 10.22x | 6.51B | |
| 2.99% | 3.29% | 14.36x | 2.16x | 0.92x | 6.67x | 8.74x | 4.07B | |
| 5.26% | 5.98% | 14.56x | 4.45x | 1.24x | 7.57x | 14.24x | 3.29B | |
| 4.28% | 4.69% | 14.99x | 6.78x | 0.91x | 6.82x | 9.48x | 3.08B | |
| 0.03% | -.--% | -116.04x | 2.84x | 0.46x | 17.06x | 88.68x | 1.53B | |
| 1.9% | 2.31% | 21.57x | 3.77x | 0.62x | 7.99x | 13.08x | 1.57B | |
| 4.06% | 4.57% | 12.51x | 0.89x | 0.3x | 2.9x | 5.98x | 992M | |
| 5.76% | 5.57% | 14.51x | 2.4x | 0.85x | 6.91x | 14.88x | 919M | |
| 1.34% | 1.95% | 26.67x | 7.27x | 0.97x | 13.16x | 20.41x | 812M | |
| 0.36% | 0.37% | 14.46x | 1.95x | 0.69x | 8.47x | 13.67x | 721M | |
| Average | 2.6% | 2.89% | 7.05x | 3.18x | 0.78x | 9.14x | 18.23x | 3.84B | |
| Weighted average by Cap. | 1.85% | 2.08% | 13.86x | 2.62x | 0.82x | 10.42x | 14.76x |
Select your edition
All financial news and data tailored to specific country editions
